欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/5285/001
药品名称Cleenema 181 mg/ml + 80 mg/ml rectal solution
活性成分
    • sodium dihydrogen phosphate dihydrate 181.0 mg/ml
    • Sodium Phosphate Anhydrous 80.0 mg/ml
剂型Rectal solution
上市许可持有人Casen Recordati, S.L. Autovia de Logroño, km. 13,300 50180 Utebo - Zaragoza Spain
参考成员国 - 产品名称Netherlands (NL)
Cleenema ready-to-use 181 mg/ml + 80 mg/ml enema
互认成员国 - 产品名称
    • Cyprus (CY)
      Cleenema 180.8 mg/ml / 79.9 mg/ml ορθικό διάλυμα
    • Austria (AT)
    • Hungary (HU)
      Cleenema ready-to-use 181 mg/ml + 80 mg/ml végbéloldat
    • Czechia (CZ)
      Cleenema ready-to-use 181 mg/ml + 80 mg/ml enema
    • Slovakia (SK)
许可日期2021/12/10
最近更新日期2024/03/12
药物ATC编码
    • A06AG01 sodium phosphate
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Bibliographic Art 10 a Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Non Prescription (including OTC)
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase